A synthetic melanocortin receptor agonist studied for central nervous system-mediated signaling effects related to desire, arousal pathways, and neuroendocrine modulation.
A synthetic melanocortin receptor agonist studied for central nervous system-mediated signaling effects related to desire, arousal pathways, and neuroendocrine modulation.
$40.00
PT-141, also known as Bremelanotide in clinical research, is a melanocortin receptor agonist derived from alpha-melanocyte-stimulating hormone analogs. It primarily targets MC3R and MC4R receptors within the central nervous system rather than peripheral vascular pathways.
In research environments, PT-141 is examined for its effects on hypothalamic signaling, dopaminergic pathways, and neuroendocrine regulation associated with libido and behavioral responses. Unlike vascular acting agents, its mechanism of action centers on neural receptor modulation. Supplied in 3ml format, this compound is intended strictly for laboratory research use only and not for human or veterinary application.
tristackpeptides@gmail.com
All products are supplied strictly for research and laboratory use only. They are not intended for human or veterinary consumption. We do not provide or support any information regarding personal use or administration.